World’s First Large-Scale, Automated Microwave Peptide Synthesizer

(Matthews, North Carolina) May 21, 2019 – CEM Corporation is proud to announce the release of the world’s first ever large-scale, automated microwave peptide synthesizer. The system, named Liberty PRO, provides for the unprecedented synthesis of up to 1 kg of crude peptide per batch utilizing reaction vessel sizes up to 15 liters. The Liberty PRO provides unmatched purity, speed,... Read more

CEM Corporation Launches New Disruptive Technology for Transforming and Simplifying Microwave Digestion

(Matthews, North Carolina, May 22, 2019) – CEM Corporation, the leading supplier of microwave digestion systems, is pleased to announce the latest breakthrough in vessel technology which dramatically simplifies and improves the overall digestion process. It allows the use of simple disposable glass vessels through the entire sample preparation process from the balance to the analyzer. This includes... Read more

CEM Corporation Launches New Disruptive Technology for Transforming and Simplifying Microwave Digestion

(Matthews, North Carolina, May 22, 2019) – CEM Corporation, the leading supplier of microwave digestion systems, is pleased to announce the latest breakthrough in vessel technology which dramatically simplifies and improves the overall digestion process. It allows the use of simple disposable glass vessels through the entire sample preparation process from the balance to the analyzer. This includes... Read more

Bruker Introduces High-Frequency Reciprocating Rig Module

High-Precision, Flexible Development of Lubrication Materials May 20, 2019 – At the 74th STLE Annual Meeting and Exhibition, Bruker today announced the release of the High-Frequency Reciprocating Rig (HFRR) Module for the UMT TriboLab™ Mechanical Tester. The new HFRR Module performs a wide range of materials qualification tests and enables effective screening of lubricants and materials at the benchtop scale... Read more

QIAGEN gains 510(k) clearance by FDA for QIAstat-Dx in the U.S. and launches system as next generation platform for syndromic insights

Germantown, Maryland, and Hilden, Germany, May 20, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of its QIAstat-Dx syndromic testing system after receiving 510(k) clearance by the U.S. Food and Drug Administration, along with the multiplex QIAstat-Dx® Respiratory Panel for simultaneous qualitative detection and identification of multiple respiratory... Read more

New State-of-the-Art Facility Increases Agilent's Capacity to Produce Nucleic Acid-Based Therapeutics

New State-of-the-Art Facility Increases Agilent’s Capacity to Produce Nucleic Acid-Based Therapeutics New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) today announced the opening of a production facility in Colorado that more than doubles its... Read more

Introducing MyPIPETMAN®, a Personalized Pipette Design Experience from Gilson

Middleton, WI (May 15, 2019) – Gilson announced today the launch of MyPIPETMAN, a new design experience that offers scientists the opportunity to build a unique pipette with the exact look and functions they require. MyPIPETMAN is a 3D interactive online configurator that lets researchers design a one-of-a-kind pipette using a variety of customization options. The... Read more

Grabner Instruments Launches New Flashpoint Tester MINIFLASH FP Vision

Wednesday, May 15, 2019 VIENNA, AUSTRIA – With AMETEK Grabner Instruments’ new flash point analyzer, the MINIFLASH FP Vision, safety comes first. The MINIFLASH FP Vision determines the flash point of flammable liquid mixtures according to ASTM D6450 and ASTM D7094. These test methods, with continuously closed-cup, are the safest for flash point testing and their... Read more

New England Biolabs® expands its Monarch Nucleic Acid Purification portfolio with a genomic DNA extraction and purification kit

A comprehensive solution for cell lysis, RNA removal and purification of intact genomic DNA from a wide variety of biological samples, including, but not limited to, cultured cells, blood and mammalian tissues. Ipswich, MA, USA (May 15th, 2019) — New England Biolabs® (NEB®) today announced the release of its Monarch Genomic DNA Purification Kit. The... Read more